Skip to main content

PAVmed Inc.

PAVM
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0001624326

No open-market purchases or sales by PAVmed Inc. insiders were filed in the last 90 days; 19 institutions reported holding it in 13F filings for Q2 2026, worth $5.56M in total; no superinvestor holds it.

Holders of 5% or more of PAVM

Holders whose latest Schedule 13D or 13G filing reports 5% or more of PAVmed Inc., largest stake first. The change is against the holder's previous filing.

Holders of 5% or more of PAVM
HolderLatest formStakeChangeFirst filedLatest filingFiling
Tasso Partners, LLC13G18.90%2.57M sharesNewFeb 28, 20251 filingFeb 28, 2025SEC
Two Seas Capital LP13G9.99%657.2K sharesNewMay 15, 20261 filingMay 15, 2026SEC
Ayrton Capital LLC13G/A9.90%1.23M shares–Feb 13, 20251 filingFeb 13, 2025SEC
Sargent Investment Group, LLC13G5.80%1.01M sharesNewAug 14, 20251 filingAug 14, 2025SEC

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

5 Schedule 13D and 13G filings on PAVmed Inc., newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on PAVM
Filed (ET)FilerFormStakeChangeEvent dateFiling
May 15, 20265:48 PM ETTwo Seas Capital LPand 2 others13G9.99%657.2K sharesNewMar 31, 2026SEC
Aug 14, 20253:19 PM ETSargent Investment Group, LLC13G5.80%1.01M sharesNewJul 1, 2025SEC
May 15, 20251:14 PM ETFirst Manhattan Co13G/A4.30%714.1K shares–Below 5%Mar 31, 2025SEC
Feb 28, 20255:29 PM ETTasso Partners, LLCand 1 other13G18.90%2.57M sharesNewFeb 21, 2025SEC
Feb 13, 20251:40 PM ETAyrton Capital LLCand 2 others13G/A9.90%1.23M shares–Dec 31, 2024SEC

Form 144: proposed insider sales

Notices from officers, directors and other affiliates planning to sell PAVmed Inc. shares.

No Form 144 notices for PAVmed Inc. are on file.